Ensysce Biosciences Statistics
Total Valuation
ENSC has a market cap or net worth of $1.76 million. The enterprise value is $1.49 million.
| Market Cap | 1.76M |
| Enterprise Value | 1.49M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, after market close.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ENSC has 3.15 million shares outstanding. The number of shares has increased by 1,158.34% in one year.
| Shares Outstanding | 3.15M |
| Shares Change (YoY) | +1,158.34% |
| Shares Change (QoQ) | -15.11% |
| Owned by Insiders (%) | 5.55% |
| Owned by Institutions (%) | 2.32% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 1.04 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.69
| Current Ratio | 0.69 |
| Quick Ratio | 0.37 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -28.99 |
Financial Efficiency
Return on equity (ROE) is -780.20% and return on invested capital (ROIC) is -2,015.31%.
| Return on Equity (ROE) | -780.20% |
| Return on Assets (ROA) | -262.40% |
| Return on Capital (ROIC) | -2,015.31% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.52M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.18% in the last 52 weeks. The beta is 0.76, so ENSC's price volatility has been lower than the market average.
| Beta (1Y) | 0.76 |
| 52-Week Price Change | -84.18% |
| 50-Day Moving Average | 0.79 |
| 200-Day Moving Average | 1.27 |
| Relative Strength Index (RSI) | 25.38 |
| Average Volume (30 Days) | 627,267 |
Short Selling Information
The latest short interest is 17,483, so 0.56% of the outstanding shares have been sold short.
| Short Interest | 17,483 |
| Short Previous Month | 56,530 |
| Short % of Shares Out | 0.56% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.09 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -10.72M |
| Pretax Income | -10.61M |
| Net Income | -10.63M |
| EBITDA | -10.26M |
| EBIT | -10.26M |
| Earnings Per Share (EPS) | -$4.69 |
Balance Sheet
The company has $1.12 million in cash and $854,697 in debt, giving a net cash position of $268,907 or $0.09 per share.
| Cash & Cash Equivalents | 1.12M |
| Total Debt | 854,697 |
| Net Cash | 268,907 |
| Net Cash Per Share | $0.09 |
| Equity / Book Value | -322,858 |
| Book Value Per Share | -0.10 |
| Working Capital | -1.04M |
Cash Flow
| Operating Cash Flow | -10.78M |
| Capital Expenditures | n/a |
| Free Cash Flow | -10.78M |
| FCF Per Share | -$4.76 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ENSC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,158.34% |
| Shareholder Yield | -1,158.34% |
| Earnings Yield | -604.63% |
| FCF Yield | -613.39% |
Analyst Forecast
The average price target for ENSC is $7.00, which is 1,153.13% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.00 |
| Price Target Difference | 1,153.13% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 31, 2023. It was a reverse split with a ratio of 1:12.
| Last Split Date | Mar 31, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |